Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.
Castella B, Foglietta M, Sciancalepore P, Rigoni M, Coscia M, Griggio V, Vitale C, Ferracini R, Saraci E, Omedé P, Riganti C, Palumbo A, Boccadoro M, Massaia M. Castella B, et al. Among authors: boccadoro m. Oncoimmunology. 2015 May 26;4(11):e1047580. doi: 10.1080/2162402X.2015.1047580. eCollection 2015 Nov. Oncoimmunology. 2015. PMID: 26451323 Free PMC article.
New drugs for treatment of multiple myeloma.
Bruno B, Rotta M, Giaccone L, Massaia M, Bertola A, Palumbo A, Boccadoro M. Bruno B, et al. Among authors: boccadoro m. Lancet Oncol. 2004 Jul;5(7):430-42. doi: 10.1016/S1470-2045(04)01511-6. Lancet Oncol. 2004. PMID: 15231250 Review.
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M, Lauta VM, Bergonzi C, Barbui A, Caravita T, Capaldi A, Pregno P, Guglielmelli T, Grasso M, Callea V, Bertola A, Cavallo F, Falco P, Rus C, Massaia M, Mandelli F, Carella AM, Pogliani E, Liberati AM, Dammacco F, Ciccone G, Boccadoro M. Palumbo A, et al. Among authors: boccadoro m. Blood. 2004 Nov 15;104(10):3052-7. doi: 10.1182/blood-2004-02-0408. Epub 2004 Jul 20. Blood. 2004. PMID: 15265788 Free article. Clinical Trial.
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.
Ladetto M, Vallet S, Trojan A, Dell'Aquila M, Monitillo L, Rosato R, Santo L, Drandi D, Bertola A, Falco P, Cavallo F, Ricca I, De Marco F, Mantoan B, Bode-Lesniewska B, Pagliano G, Francese R, Rocci A, Astolfi M, Compagno M, Mariani S, Godio L, Marino L, Ruggeri M, Omedè P, Palumbo A, Boccadoro M. Ladetto M, et al. Among authors: boccadoro m. Blood. 2005 Jun 15;105(12):4784-91. doi: 10.1182/blood-2004-11-4201. Epub 2005 Feb 24. Blood. 2005. PMID: 15731178 Free article.
The future role of thalidomide in multiple myeloma.
Boccadoro M, Blade J, Attal M, Palumbo A. Boccadoro M, et al. Acta Haematol. 2005;114 Suppl 1:18-22. doi: 10.1159/000087040. Acta Haematol. 2005. PMID: 16166768 Review.
511 results